Healthcare professional reviewing medical imaging on a computer workstation at the Aga Khan University in Keyna, illustrating the use of digital technology in cancer diagnosis and treatment planning.

The Access to Oncology Medicines (ATOM) Coalition partner Cepheid has made its first mRNA precision diagnostics for chronic myeloid leukaemia (CML) monitoring available to low- and lower-middle-income countries (LLMICs).

Precision diagnostics for CML now available...
Maxcare Foundation Nigeria
CML Zimbabwe Trust
Fundación Esperanza Nueva
Ethiopia CML Patients Association
FAQ tobacco control
This FAQ provides clear and accessible answers to the most common questions on tobacco control, outlining why it matters, the health risks of tobacco use, and the policies proven to reduce harm and save lives.
FAQ Tobacco control

This policy aims to support UICC’s commitment to integrity, transparency, and accountability by preventing, detecting, and responding to fraud and corruption across all operations, partnerships, and governance structures.

Anti-corruption and Fraud Policy

World Cancer Leaders' Summit 2027 (WCLS2027)

Date and time
02 November - 05 November
Location

Kenyatta International Convention Centre
Harambee Avenue, Nairobi City Square.
Nairobi
00100
Kenya

Organiser(s):
Union for International Cancer Control (UICC)
Preview Text

The World Cancer Leaders’ Summit will take place in Nairobi, Kenya, from 2–5 November 2027, marking the Summit’s return to Africa and reflecting the continent’s growing role in shaping global cancer control.

The National Cancer Institute of Kenya (NCI-Kenya) is a state corporation established under the Cancer Prevention and Control Act of 2012 to coordinate the national response to cancer.

It provides leadership, policy advice, research, public education, and manages the national cancer registry, working with partners to reduce the cancer burden and improve access to quality cancer care across Kenya.

Learn more here
Subscribe to